Pharmacologic Inhibition of Pain Response to Incomplete Vascular Occlusion Blunts Cardiovascular Preconditioning Response

Akiva Kirschner,Sheryl E. Koch,Nathan Robbins,Felix Karthik,Parvathi Mudigonda,Ranjani Ramasubramanian,Michelle L. Nieman,John N. Lorenz,Jack Rubinstein
DOI: https://doi.org/10.1007/s12012-021-09680-z
2021-07-29
Cardiovascular Toxicology
Abstract:Complete vascular occlusion to distant tissue prior to an ischemic cardiac event can provide significant cardioprotection via remote ischemic preconditioning (RIPC). Despite understanding its mechanistic basis, its translation to clinical practice has been unsuccessful, likely secondary to the inherent impossibility of predicting (and therefore preconditioning) an ischemic event, as well as the discomfort that is associated with traditional, fully occlusive RIPC stimuli. Our laboratory has previously shown that non-occlusive banding (NOB) via wrapping of a leather band (similar to a traditional Jewish ritual) can elicit an RIPC response in healthy human subjects. This study sought to further the pain-mediated aspect of this observation in a mouse model of NOB with healthy mice that were exposed to treatment with and without lidocaine to inhibit pain sensation prior to ischemia/reperfusion injury. We demonstrated that NOB downregulates key inflammatory markers resulting in a preconditioning response that is partially mediated via pain sensation.
cardiac & cardiovascular systems,toxicology
What problem does this paper attempt to address?